Literature DB >> 2882081

Deposits of eosinophil granule proteins in cardiac tissues of patients with eosinophilic endomyocardial disease.

P C Tai, S J Ackerman, C J Spry, S Dunnette, E G Olsen, G J Gleich.   

Abstract

Eosinophilic endomyocardial disease is a complication of the hypereosinophilic syndrome and of several other disorders associated with high blood eosinophil counts. Eosinophil granule proteins may be involved in the development of these lesions. This multi-centre study investigated whether these proteins could be demonstrated within the cardiac tissues of eighteen patients with eosinophilic endomyocardial disease. Serial sections of tissue taken at necropsy or at cardiac biopsy were stained for eosinophil major basic protein by indirect immunofluorescence and for eosinophil cationic protein, eosinophil protein-X, and activated eosinophils by means of alkaline-phosphatase-linked monoclonal antibodies. Activated eosinophils and secreted eosinophil granule proteins were most evident within the necrotic and later stage thrombotic lesions and were found mainly within the areas of acute tissue damage in the endocardium and in the walls of small blood vessels. These findings suggest that eosinophil granule proteins are involved in cardiac injury, producing muscle damage and vascular injury which lead to the development of endomyocardial fibrosis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2882081     DOI: 10.1016/s0140-6736(87)90412-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  69 in total

1.  Idiopathic hypereosinophilic syndrome involving thoracic spine.

Authors:  Chi Young Park; Seok Won Kim
Journal:  J Korean Neurosurg Soc       Date:  2010-05-31

2.  Improvement of eosinophilic heart disease after steroid therapy: successful demonstration by endomyocardial biopsied specimens.

Authors:  S Hayashi; M Isobe; Y Okubo; J Suzuki; Y Yazaki; M Sekiguchi
Journal:  Heart Vessels       Date:  1999       Impact factor: 2.037

Review 3.  Cardiac manifestation of the hypereosinophilic syndrome: new insights.

Authors:  T Kleinfeldt; C A Nienaber; S Kische; I Akin; R G Turan; T Körber; H Schneider; H Ince
Journal:  Clin Res Cardiol       Date:  2010-03-24       Impact factor: 5.460

4.  Sudden unexpected death in childhood due to eosinophilic myocarditis.

Authors:  Y Aoki; M Nata; M Hashiyada; K Sagisaka
Journal:  Int J Legal Med       Date:  1996       Impact factor: 2.686

Review 5.  Contributions of electron microscopy to understand secretion of immune mediators by human eosinophils.

Authors:  Rossana C N Melo; Ann M Dvorak; Peter F Weller
Journal:  Microsc Microanal       Date:  2010-09-27       Impact factor: 4.127

Review 6.  Relationships between eosinophilic inflammation, tissue remodeling, and fibrosis in eosinophilic esophagitis.

Authors:  Seema S Aceves; Steven J Ackerman
Journal:  Immunol Allergy Clin North Am       Date:  2009-02       Impact factor: 3.479

7.  Progressive dilated cardiomyopathy in a patient with longstanding and complete prednisone-induced hematological remission of idiopathic hypereosinophilic syndrome.

Authors:  R Christen; R Morant; J Schneider; R Jenni; J Fehr
Journal:  Klin Wochenschr       Date:  1989-03-15

Review 8.  Standard and etiology-directed evidence-based therapies in myocarditis: state of the art and future perspectives.

Authors:  Bernhard Maisch; Sabine Pankuweit
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

9.  Effects of monoclonal antibodies to adhesion molecules on eosinophilic myocarditis in Toxocara canis-infected CBA/J mice.

Authors:  S Hokibara; M Takamoto; M Isobe; K Sugane
Journal:  Clin Exp Immunol       Date:  1998-11       Impact factor: 4.330

10.  Eosinophilic myocarditis in CBA/J mice infected with Toxocara canis.

Authors:  M Cookston; M Stober; S G Kayes
Journal:  Am J Pathol       Date:  1990-05       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.